Clover Health Investments (CLOV) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Clover Health Investments (CLOV) is Neutral.

The composite score behind that read is -0.15, weighing +0.09 of bullish evidence against -0.32 bearish.

Clover Health Investments last closed at $4.38, +3.55% on the session.

Against the IVW growth benchmark the position is +2.58% over the forecast window.

The read is built from 11 underlying insights — 4 bullish and 7 bearish.

Agreement across those insights is 64%.

7 graded predictions for CLOV so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Clover Health Investments in the 35th percentile on return on equity, where 100 is best.

Clover Health Investments is classified under Health Care / Health Care Providers & Services, with a market capitalisation of $2.25B.

StockMap tracks Clover Health Investments as the 31st largest of the 51 companies it covers in the Health Care Providers & Services industry, part of the Health Care sector.

Across that group the current two-week reads are 35 Neutral and 16 Moderate Underperform.

On that composite Clover Health Investments ranks 28th of 51 in the group, against a group median of -0.13.

Other Health Care stocks

Clover Health Investments (CLOV) — StockMap 2-week forecast & tracked accuracy